About InterMed Discovery
InterMed Discovery is a Natural Product lead-discovery company, driving innovation through the generation of product candidates for the life science, food and cosmetics industries. Using a powerful validated Natural Product discovery engines, InterMed Discovery generates product pipelines of early stage pharmaceuticals and functional ingredients and also supports partners in research and lead generation.
Missing: InterMed Discovery's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: InterMed Discovery's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest InterMed Discovery News
Nov 29, 2016
Home » Topics » Alliances, mergers acquisitions and partnerships » Latest News » InterMed Discovery GmbH Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' InterMed Discovery GmbH Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by InterMed Discovery GmbH since January 2007. Key Findings Provides intelligence on InterMed Discovery GmbH MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by InterMed Discovery GmbH and its subsidiaries since 2007. Information about key financial and legal advisors for InterMed Discovery GmbH's financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about InterMed Discovery GmbH's growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News
InterMed Discovery Frequently Asked Questions (FAQ)
When was InterMed Discovery founded?
InterMed Discovery was founded in 2005.
What is InterMed Discovery's latest funding round?
InterMed Discovery's latest funding round is Other Investors.
Who are the investors of InterMed Discovery?
Investors of InterMed Discovery include High-Tech Grunderfonds and Cognis.
Who are InterMed Discovery's competitors?
Competitors of InterMed Discovery include MicuRx Pharmaceuticals, MerLion Pharmaceuticals, Global Integrity, Fluxion Biosciences, CytoBioscience and 12 more.
Compare InterMed Discovery to Competitors
Sword Diagnostics is a life sciences company created in response to the needs of the research, pharmaceutical, and clinical communities. Although researchers are discovering thousands of biomarkers associated with both healthy and diseased-related biological processes, today's life science tools are unable to effectively measure, quantify, and determine the ultimate value of these biological markers. Sword Diagnostics' technology is directly aimed at making it easier to understand these newly emerging biomarkers, as well as extending the utility of existing diagnostics assays. Sword's mission is to provide the next-generation detection technology to life scientists, enabling them to continue advances in medical research, drug discovery and the provision of health care products and services.
Fluxion Biosciences is a developer of precision solutions for life science research and diagnostics. Fluxion's liquid biopsy solutions are changing how cancer is detected and treated. Fluxion's pioneering liquid biopsy technologies include the IsoFlux CTC Liquid Biopsy System, ERASE-Seq ultra-sensitive variant caller, and the Spotlight 59 NGS Oncology Panel for cancer mutation detection from cell-free circulating tumor DNA. Fluxion's technologies are used globally by cancer centers developing new tests for early cancer detection and patient monitoring.
AC PharmaChem, Inc. is a fast growing company providing contract research and development services of medicinal chemistry, customer based organic synthesis of special chemical reagents, intermediates, reference compounds, and synthesis of focused libraries. The company's goal is to fully support the company's pharmaceutical and biotech partners to speed up and advance their drug discovery and innovation processes. At AC PharmaChem, the company have experienced medicinal and synthetic chemists utilizing synthetic techniques and instruments to provide cost efficient and on time delivery to meet the demands of the company's customers.
Promega is engaged in applying biochemistry and molecular biology to the development of high-value biological reagents and systems for the life sciences industry.
Gentronix provides toxicology testing services for pharmaceuticals, agrochemicals, cosmetics, personal care and consumer products. The company enables major global brands to perform hazard and safety assessments, from early-stage discovery through to regulatory submission and approval.
The scientists at Genomic Solutions have a wealth of genomic, protein analysis and nano-liter dispensing application-based expertise that they would like to share with users. First select their area of research, followed by interest and then application, and finally, to the company's instrumentation which can help facilitate their research. Whether users are involved in the life science or biotechnology research community, the company's products will enable users to perform complex, high volume experiments at a lower cost and in less time than traditional techniques. You achieve rapid and less expensive drug discovery.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.